chr12-71941585-T-G
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_173353.4(TPH2):c.107T>G(p.Leu36Arg) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L36V) has been classified as Likely benign.
Frequency
Consequence
NM_173353.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPH2 | ENST00000333850.4 | c.107T>G | p.Leu36Arg | missense_variant, splice_region_variant | Exon 2 of 11 | 1 | NM_173353.4 | ENSP00000329093.3 | ||
TPH2 | ENST00000546576.1 | n.117T>G | splice_region_variant, non_coding_transcript_exon_variant | Exon 2 of 7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152094Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250796 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461564Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727078 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74292 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.107T>G (p.L36R) alteration is located in exon 2 (coding exon 2) of the TPH2 gene. This alteration results from a T to G substitution at nucleotide position 107, causing the leucine (L) at amino acid position 36 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at